US Patent Issued to The Chinese University of Hong Kong on Oct. 7 for "Self-therapeutic nanoparticle for enhanced topical delivery to skin keratinocytes and treating skin inflammation" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,433,958, issued on Oct. 7, was assigned to The Chinese University of Hong Kong (Hong Kong).

"Self-therapeutic nanoparticle for enhanced topical delivery to skin keratinocytes and treating skin inflammation" was invented by Chung Hang Jonathan Choi (Hong Kong), Ruifang Han (Henan, China) and Lok Wai Cola Ho (Hong Kong).

According to the abstract* released by the U.S. Patent & Trademark Office: "A composition of an anti-psoriatic drug and methods of applying the anti-psoriatic drug for transdermal delivery of nanoparticles and entry into skin cells are provided. The composition of the anti-psoriatic drug includes a core having at least one gold nanoparticle, a shell of polyethylene glyc...